News for hackers. Stuff that matters.
Re:The Most Unconscionable Drug Price Hike I Have Yet Seen by throwaway5752 on Thursday September 11, 2014 @11:17AM (#8303030)
"Valeant" is all you have to say. You can see what the In the Pipeline author thinks of that company by reading the archives, too. Or any number of other chem/r&d pharma blogs. In particular a lot of ink has been spilled over their ongoing hostile bid for Allergan.

Valeant has a controversial business model. The acquire successful R&D pharma organizations, drastically cut R&D spends, raise drug prices, and then use accounting (IMO) to understate R&D costs as goodwill/depreciation for the acquisitions. Not a fan.

There are no comments on this comment yet.